The signature of a T-cell response to KSHV persists across space and time in individuals with epidemic and endemic KS from Uganda.
Shashidhar RavishankarAndrea M H TowlertonPeter MookaJames KafeeroDavid G CoffeyLauri D AicherKelvin R MubiruLazarus OkochePrisca AtwinirembabaziJoseph OkonyeWarren T PhippsEdus H WarrenPublished in: bioRxiv : the preprint server for biology (2024)
Transcriptional profiling and T-cell receptor repertoire analysis of tumor biopsies from 144 Ugandan adults with KS demonstrate that a systemic, persistent, polyspecific KSHV-specific T-cell response exists and is likely inhibited by M2 macrophages within the tumor micro-environment.